Implications of proteasome inhibition: An enhanced macrophage phenotype

Cellular Immunology

Volumn 227, Issue 2, 2004, Pages 140-147

  Cuschieri, Joseph ^a   Gourlay, David ^b   Garcia, Iris ^b   Jelacic, Sandra ^b   Maier, Ronald V ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AP 1; Chemokine; Cytokine; Endotoxin; ERK 1 2; JNK SAPK; Macrophage; NF B; P38; Proteasome

Indexed keywords

APOLIPOPROTEIN A1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LACTACYSTIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTRANSFERASE; PROTEASOME; PROTEASOME INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MACROPHAGE; PHENOTYPE; PREMEDICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL LINE; CYSTEINE ENDOPEPTIDASES; ENDOTOXINS; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-8; MACROPHAGE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIENZYME COMPLEXES; NF-KAPPA B; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342630414     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.03.005     Document Type: Article

References (25)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:2001;1303-1310
2. Baue A.E., Durham R., Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock. 10:1998;79-89
3. Fein A.M., Calalang-Colucci M.G. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit. Care Clin. 16:2000;289-317
4. Goya T., Abe M., Shimura H., Torisu M. Characteristics of alveolar macrophages in experimental septic lung. J. Leukoc. Biol. 52:1992;236-243
5. Heumann D., Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin. Chim. Acta. 323:2002;59-72
6. Zhang F.X., Kirschning C.J., Mancinelli R., Xu X.P., Jin Y., Faure E., Mantovani A., Rothe M., Muzio M., Arditi M. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:1999;7611-7614
7. Swantek J.L., Tsen M.F., Cobb M.H., Thomas J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:2000;4301-4306
8. Griscavage J.M., Wilk S., Ignarro L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl, Acad. Sci. USA. 93:1996;3308-3312
9. Dignam J.D., Martin P.L., Shastry B.S., Roeder R.G. Eukaryotic gene transcription with purified components. Methods Enzymol. 101:1983;582-598
10. Chow C.W., Grinstein S., Rotstein O.D. Signaling events in monocytes and macrophages. New Horiz. 3:1995;342-351
11. Schroder N.W., Opitz B., Lamping N., Michelsen K.S., Zahringer U., Gobel U.B., Schumann R.R. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J. Immunol. 165:2000;2683-2693
12. Janssens S., Beyaert R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell. 11:2003;293-302
13. Yamin T.T., Miller D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272:1997;21540-21547
14. Q. Wang, R. Dziarski, C.J. Kirschning, M. Muzio, D. Gupta, Micrococci and peptidoglycan activate TLR2-> MyD88-> IRAK-> TRAF-> NIK-> IKK-> NF-kappaB signal transduction pathway that induces transcription of interleukin-8, Infect. Immun. 69 (2001) 2270-2276
15. Haas M., Page S., Page M., Neumann F.J., Marx N., Adam M., Ziegler-Heitbrock H.W., Neumeier D., Brand K. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production. J. Leukoc. Biol. 63:1998;395-404
16. Dick L.R., Cruikshank A.A., Grenier L., Melandri F.D., Nunes S.L., Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J. Biol. Chem. 271:1996;7273-7276
17. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. Embo J. 20:2001;7108-7116
18. Chen P., Li J., Barnes J., Kokkonen G.C., Lee J.C., Liu Y. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169:2002;6408-6416
19. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 13:2001;85-94
20. Neumann B., Zantl N., Veihelmann A., Emmanuilidis K., Pfeffer K., Heidecke C.D., Holzmann B. Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int. Immunol. 11:1999;217-227
21. Liu H.S., Pan C.E., Liu Q.G., Yang W., Liu X.M. Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis. World J. Gastroenterol. 9:2003;2513-2518
22. Fine S.M., Maggirwar S.B., Elliott P.R., Epstein L.G., Gelbard H.A., Dewhurst S. Proteasome blockers inhibit TNF-alpha release by lipopolysaccharide stimulated macrophages and microglia: implications for HIV-1 dementia. J. Neuroimmunol. 95:1999;55-64
23. Adib-Conquy M., Moine P., Asehnoune K., Edouard A., Espevik T., Miyake K., Werts C., Cavaillon J.M. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am. J. Respir. Crit. Care Med. 168:2003;158-164
24. Nakamura A., Johns E.J., Imaizumi A., Yanagawa Y., Kohsaka T. Modulation of interleukin-6 by beta2-adrenoceptor in endotoxin-stimulated renal macrophage cells. Kidney Int. 56:1999;839-849
25. Bode J.G., Peters-Regehr T., Schliess F., Haussinger D. Activation of mitogen-activated protein kinases and IL-6 release in response to lipopolysaccharides in Kupffer cells is modulated by anisoosmolarity. J. Hepatol. 28:1998;795-802